Literature DB >> 17408764

Diabetic type II Goto-Kakizaki rats show progressively decreasing exploratory activity and learning impairments in fixed and progressive ratios of a lever-press task.

Tiago Moreira1, Ewa Malec, Claes-Göran Ostenson, Suad Efendic, Sture Liljequist.   

Abstract

Learning and memory impairments associated with diabetes have been reproduced in rodent models of diabetes type I, but few studies have been performed in spontaneously type II diabetic rodents. The study of type II diabetic rats such as the Goto-Kakizaki (GK) rat is of advantage when characterizing the development of cognitive impairments specifically caused by the progression of the disease and not by its treatment. We thus hypothesized that GK rats might display learning impairments when compared to non-diabetic Wistar rats. In the present study, we employed a lever-press task, a behavioural paradigm which allows the study of response-reinforcement learning, discrimination of a rewarding lever (using a two-choice positional discrimination task), and the ability to increase operant behaviour when requirements for reward increase (using a progressive ratio [PR]). In parallel, locomotor activity was compared between strains to assess exploratory activity and behavioural habituation to a novel environment. Diabetic GK rats made significantly less lever-presses with increasing fixed ratios and, throughout the sessions, a trend for increased selection errors was observed in these animals. In addition, a significant reduction in the maximum number of lever-presses made by GK rats was observed during the PR sessions. Locomotor activity of GK rats was higher on the first day of exploration but significantly decreased with familiarization to the environment. The present results suggest that the diabetic-like symptomatology in GK rats led to a reduction of exploratory activity and of lever-pressing during fixed and progressive ratio schedules, likely caused by learning impairments.

Entities:  

Mesh:

Year:  2007        PMID: 17408764     DOI: 10.1016/j.bbr.2007.02.034

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  7 in total

1.  Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology.

Authors:  E Candeias; A I Duarte; I Sebastião; M A Fernandes; A I Plácido; C Carvalho; S Correia; R X Santos; R Seiça; M S Santos; C R Oliveira; P I Moreira
Journal:  Mol Neurobiol       Date:  2016-10-11       Impact factor: 5.590

2.  Examination of nicotine and saccharin reward in the Goto-Kakizaki diabetic rat model.

Authors:  Janell R Richardson; Laura E O'Dell; Arbi Nazarian
Journal:  Neurosci Lett       Date:  2020-02-06       Impact factor: 3.046

Review 3.  Peripheral versus central insulin and leptin resistance: Role in metabolic disorders, cognition, and neuropsychiatric diseases.

Authors:  Jennifer M Erichsen; Jim R Fadel; Lawrence P Reagan
Journal:  Neuropharmacology       Date:  2021-11-08       Impact factor: 5.250

4.  Sevoflurane Induces Exaggerated and Persistent Cognitive Decline in a Type II Diabetic Rat Model by Aggregating Hippocampal Inflammation.

Authors:  Dongliang Li; Lingling Liu; Liang Li; Xingang Li; Bin Huang; Changqing Zhou; Zhaohang Zhang; Chunling Wang; Ping Dong; Xiyan Zhang; Bo Yang; Li Zhang
Journal:  Front Pharmacol       Date:  2017-11-29       Impact factor: 5.810

5.  Mitochondrial nutrients improve immune dysfunction in the type 2 diabetic Goto-Kakizaki rats.

Authors:  Jiejie Hao; Weili Shen; Chuan Tian; Zhongbo Liu; Jinmin Ren; Cheng Luo; Jiangang Long; Edward Sharman; Jiankang Liu
Journal:  J Cell Mol Med       Date:  2008-04-10       Impact factor: 5.310

6.  Type 2 diabetes-induced neuronal pathology in the piriform cortex of the rat is reversed by the GLP-1 receptor agonist exendin-4.

Authors:  Grazyna Lietzau; Thomas Nyström; Claes-Göran Östenson; Vladimer Darsalia; Cesare Patrone
Journal:  Oncotarget       Date:  2016-02-02

7.  Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin.

Authors:  Grazyna Lietzau; William Davidsson; Claes-Göran Östenson; Fausto Chiazza; David Nathanson; Hiranya Pintana; Josefin Skogsberg; Thomas Klein; Thomas Nyström; Vladimer Darsalia; Cesare Patrone
Journal:  Acta Neuropathol Commun       Date:  2018-02-23       Impact factor: 7.801

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.